[The pharmacokinetic modification of mutagenesis].
The mutagenic activity of some antitumor agents and the antituberculous agent isoniazid was studied by using some methods for estimating mutations on the Drosophila, mammals, and human cells. It was shown that mutagenic effects could be modified by adding various auxiliaries to the formulations of the drugs. The mechanisms of modifications were examined by pharmacokinetic techniques.